Jennifer Conway
A5059169450- Mechanical Circulatory Support Devices
- Cardiac Structural Anomalies and Repair
- Transplantation: Methods and Outcomes
- Congenital Heart Disease Studies
- Cardiac Arrest and Resuscitation
- Heart Failure Treatment and Management
- Cardiomyopathy and Myosin Studies
- Cardiac pacing and defibrillation studies
- Renal Transplantation Outcomes and Treatments
- Organ Transplantation Techniques and Outcomes
- Cardiovascular Function and Risk Factors
- Muscle Physiology and Disorders
- Cardiovascular Effects of Exercise
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiovascular Issues in Pregnancy
- Adolescent and Pediatric Healthcare
- Infant Development and Preterm Care
- Viral Infections and Immunology Research
- Family and Disability Support Research
- Respiratory Support and Mechanisms
- Pediatric Pain Management Techniques
- Congenital Anomalies and Fetal Surgery
- Pharmaceutical studies and practices
- Infective Endocarditis Diagnosis and Management
Stollery Children's Hospital
2016-2025
University of Alberta
2016-2025
Boston Children's Hospital
2025
Alberta Hospital Edmonton
2016-2025
University of Alberta Hospital
2025
Children's of Alabama
2024
International Society for Heart and Lung Transplantation
2024
IFC Research (United Kingdom)
2024
Piedmont Atlanta Hospital
2024
Women and Children’s Health Research Institute
2021-2023
Hypertrophic cardiomyopathy is the leading cause of sudden cardiac death (SCD) in children and young adults. Our objective was to develop validate a SCD risk prediction model pediatric hypertrophic guide prevention strategies. In an international multicenter observational cohort study, phenotype-positive patients with isolated <18 years age at diagnosis were eligible. The primary outcome variable time from composite events 5-year follow-up: SCD, resuscitated arrest, aborted that is,...
Thrombotic and bleeding complications have historically been major causes of morbidity mortality in pediatric ventricular assist device (VAD) support. Standard anticoagulation with unfractionated heparin is fraught problems related to its heterogeneous biochemical composition unpredictable pharmacokinetics. We sought describe the utilization outcomes children paracorporeal VAD support who are treated direct thrombin inhibitors (DTIs) antithrombosis therapy. Retrospective multicenter review...
Improving the outcomes of pediatric patients with congenital heart disease end-stage failure depends on collaboration all stakeholders; this includes providers, and families, industry representatives. Because rarity condition heterogeneity etiologies that occur at centers, learnings must be shared between institutions disciplines to move field forward. To foster collaboration, excel discovery, bring data bedside, a new, collaborative quality improvement science network—ACTION (Advanced...
Organ availability and acceptability limit pediatric HTx. What characteristics define an unacceptable or high-risk donor remains unclear. The purpose of this study was to characterize a large cohort donors determine the risk factors, including cumulative risk, that affect recipient survival. Data from PHTS, prospective multicenter study, were used examine impact factors on outcomes patients listed <18 yr age who received HTx between 1993 2009. Donor data available for 3149 3156 (99.8%)....
Genetic defects in the RAS/mitogen-activated protein kinase pathway are an important cause of hypertrophic cardiomyopathy (RAS-HCM). Unlike primary HCM (P-HCM), risk sudden cardiac death (SCD) and long-term survival RAS-HCM poorly understood.The study's objective was to compare transplant-free survival, incidence SCD, implantable cardioverter-defibrillator (ICD) use between P-HCM patients.In international, 21-center cohort study, we analyzed phenotype-positive pediatric (n = 188) 567)...
With continued medical and surgical advancements, most children adolescents with congenital heart disease are expected to survive adulthood. Chronic failure is increasingly being recognized as a major contributor ongoing morbidity mortality in this population it ages, treatment strategies prevent treat the pediatric needed. In addition primary myocardial dysfunction, anatomical pathophysiological abnormalities specific various lesions contribute development of affect potential commonly used...